This site may require a log-in in the near future. We are constantly being swamped by AI agents. If they continue to take down the site, we will be changing to requiring logins to access any item.

🍽️ beta-escin non-drug

AI Engines For more Details: PerplexityKagi LabsYou

  1. Venous Insufficiency: Beta-escin is commonly used in the treatment of chronic venous insufficiency (CVI), a condition characterized by impaired blood flow in the veins, usually in the legs. It helps strengthen and tone the walls of the veins, reducing inflammation and leakage of fluids into the surrounding tissues. Beta-escin may alleviate symptoms of CVI, such as leg swelling, pain, heaviness, and cramping, and improve venous circulation.

  2. Varicose Veins: Beta-escin is also used in the management of varicose veins, which are enlarged, twisted veins that typically occur in the legs. It helps reduce venous congestion and inflammation, improve venous tone and elasticity, and decrease capillary permeability. Beta-escin may alleviate symptoms associated with varicose veins, such as pain, swelling, itching, and skin discoloration.

  3. Hemorrhoids: Beta-escin is sometimes used topically or orally to relieve symptoms of hemorrhoids, which are swollen and inflamed veins in the rectum and anus. It helps reduce swelling, inflammation, and discomfort associated with hemorrhoids and may promote healing of anal fissures and ulcers. Beta-escin may be formulated into creams, ointments, suppositories, or oral preparations for the treatment of hemorrhoids.

  4. Edema: Beta-escin has mild diuretic properties and may help reduce edema (fluid retention) by increasing urine production and promoting fluid excretion from the body. It may be used as an adjunctive therapy for managing edema associated with conditions such as heart failure, kidney disease, liver cirrhosis, and lymphedema. Beta-escin may help alleviate swelling and improve symptoms of fluid overload.

  5. Anti-inflammatory Effects: Beta-escin exhibits anti-inflammatory properties and may help reduce inflammation in various tissues and organs. It inhibits the release of pro-inflammatory mediators and cytokines, decreases vascular permeability, and suppresses leukocyte migration and activation. Beta-escin may be beneficial in inflammatory conditions such as arthritis, tendonitis, bursitis, and dermatitis.

  6. Antioxidant Activity: Beta-escin has antioxidant properties and may help neutralize free radicals and reactive oxygen species (ROS) that contribute to oxidative stress and tissue damage. It scavenges free radicals, enhances antioxidant defenses, and protects cells and tissues from oxidative damage. Beta-escin may have potential applications in preventing or mitigating oxidative stress-related diseases and aging-related disorders.

  7. Wound Healing: Beta-escin may promote wound healing by stimulating tissue repair and regeneration processes. It helps reduce inflammation, edema, and pain at the wound site, improves blood flow and oxygenation, and enhances the formation of granulation tissue and collagen deposition. Beta-escin may be used in the management of chronic wounds, such as venous ulcers, pressure ulcers, and diabetic foot ulcers.

;

Check for interactions on Supp.AI   |   πŸ“š PubMed Citations

Data Contradictions β€” Limits of Certainity

Impacted of beta-escin non-drug On Probiotics

Rank Probiotic Impact
genus Bifidobacterium Reduces
species Bacteroides uniformis Reduces
species Bifidobacterium adolescentis Reduces
species Bifidobacterium breve Reduces
species Bifidobacterium longum Reduces
species Escherichia coli Reduces
species Lacticaseibacillus paracasei Reduces
subspecies Bifidobacterium longum subsp. infantis Reduces
subspecies Bifidobacterium longum subsp. longum Reduces

Bacteria Impacted by beta-escin non-drug

We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.

πŸ§™?

πŸ““ Direct Citations πŸ‘ͺπŸ‘Ά Indirect Citations Taxonomy Rank Effect
0 1 Lacrimispora genus Decreases
0 1 Bilophila genus Decreases
0 1 Segatella genus Decreases
0 1 Clostridioides genus Decreases
0 1 Escherichia genus Decreases
0 1 Collinsella genus Decreases
0 1 Shigella genus Decreases
0 1 Ruminococcus genus Decreases
0 1 Bifidobacterium genus Decreases
0 1 Parabacteroides genus Decreases
0 1 Parolsenella genus Decreases
0 1 Blautia genus Decreases
0 1 Bacteroides genus Decreases
0 1 Veillonella genus Decreases
0 1 Roseburia genus Decreases
0 1 Mediterraneibacter genus Decreases
0 1 Coprococcus genus Decreases
0 1 Streptococcus genus Decreases
0 1 Lacticaseibacillus genus Decreases
0 1 Enterocloster genus Decreases
0 1 Clostridium genus Decreases
0 1 Escherichia coli O1:K1:H7 no rank Decreases
0 1 Escherichia coli O139:H1 no rank Decreases
0 1 Escherichia coli O141:H4 no rank Decreases
0 1 Escherichia coli O145:H34 no rank Decreases
0 1 Escherichia coli O15:H12 no rank Decreases
0 1 Escherichia coli O155:H21 no rank Decreases
0 1 Escherichia coli O158:H23 no rank Decreases
0 1 Escherichia coli O16:H48 no rank Decreases
0 1 Escherichia coli O170:H18 no rank Decreases
0 1 Escherichia coli O18ac:H14 no rank Decreases
0 1 Escherichia coli O19:H7 no rank Decreases
0 1 Escherichia coli O2:K1:H4 no rank Decreases
0 1 Escherichia coli O2:K1:H5 no rank Decreases
0 1 Escherichia coli O2:K1:H7 no rank Decreases
0 1 Escherichia coli O20:H12 no rank Decreases
0 1 Escherichia coli O25:H16 no rank Decreases
0 1 Escherichia coli O55:H7 no rank Decreases
0 1 Escherichia coli O68:H12 no rank Decreases
0 1 Escherichia coli O7:H15 no rank Decreases
0 1 Escherichia coli O78:H51 no rank Decreases
0 1 Escherichia coli O80:H26 no rank Decreases
0 1 Escherichia coli O84:H7 no rank Decreases
0 1 Escherichia coli O85:H1 no rank Decreases
0 1 Clostridium perfringens A no rank Decreases
0 1 Clostridium perfringens B no rank Decreases
0 1 Clostridium perfringens C no rank Decreases
0 1 Clostridium perfringens CPE no rank Decreases
0 1 Clostridium perfringens D no rank Decreases
0 1 Clostridium perfringens E no rank Decreases
0 1 Escherichia coli O103 serogroup Decreases
0 1 Escherichia coli O111 serogroup Decreases
0 1 Escherichia coli O119 serogroup Decreases
0 1 Escherichia coli O121 serogroup Decreases
0 1 Escherichia coli O145 serogroup Decreases
0 1 Escherichia coli O155 serogroup Decreases
0 1 Escherichia coli O157 serogroup Decreases
0 1 Escherichia coli O177 serogroup Decreases
0 1 Escherichia coli O26 serogroup Decreases
0 1 Escherichia coli O3 serogroup Decreases
0 1 Escherichia coli O43 serogroup Decreases
0 1 Escherichia coli O5 serogroup Decreases
0 1 Escherichia coli O78 serogroup Decreases
0 1 Escherichia coli O86 serogroup Decreases
0 1 Escherichia coli O91 serogroup Decreases
0 1 Escherichia coli H20 serotype Decreases
0 1 Escherichia coli O1:H42 serotype Decreases
0 1 Escherichia coli O1:HNT serotype Decreases
0 1 Escherichia coli O10:H32 serotype Decreases
0 1 Escherichia coli O10:K5(L):H4 serotype Decreases
0 1 Escherichia coli O100:H21 serotype Decreases
0 1 Escherichia coli O103:H11 serotype Decreases
0 1 Escherichia coli O103:H2 serotype Decreases
0 1 Escherichia coli O103:H25 serotype Decreases
0 1 Escherichia coli O104:H21 serotype Decreases
0 1 Escherichia coli O104:H4 serotype Decreases
0 1 Escherichia coli O111:H- serotype Decreases
0 1 Escherichia coli O111:H11 serotype Decreases
0 1 Escherichia coli O111:H8 serotype Decreases
0 1 Escherichia coli O111:NM serotype Decreases
0 1 Escherichia coli O112ab:H8 serotype Decreases
0 1 Escherichia coli O112ac:H19 serotype Decreases
0 1 Escherichia coli O113:H21 serotype Decreases
0 1 Escherichia coli O114:H49 serotype Decreases
0 1 Escherichia coli O118:H16 serotype Decreases
0 1 Escherichia coli O121:H19 serotype Decreases
0 1 Escherichia coli O121:H7 serotype Decreases
0 1 Escherichia coli O123:H11 serotype Decreases
0 1 Escherichia coli O125ac:K+:H10 serotype Decreases
0 1 Escherichia coli O126:H45 serotype Decreases
0 1 Escherichia coli O127:H27 serotype Decreases
0 1 Escherichia coli O127:H6 serotype Decreases
0 1 Escherichia coli O128:H2 serotype Decreases
0 1 Escherichia coli O128ac:H12 serotype Decreases
0 1 Escherichia coli O139:H28 serotype Decreases
0 1 Escherichia coli O145:H25 serotype Decreases
0 1 Escherichia coli O145:H28 serotype Decreases
0 1 Escherichia coli O145:NM serotype Decreases
0 1 Escherichia coli O146:H21 serotype Decreases
0 1 Escherichia coli O15:H18 serotype Decreases
0 1 Escherichia coli O150:H6 serotype Decreases
0 1 Escherichia coli O152:H23 serotype Decreases
0 1 Escherichia coli O153:H2 serotype Decreases
0 1 Escherichia coli O156:H25 serotype Decreases
0 1 Escherichia coli O157:H- serotype Decreases
0 1 Escherichia coli O157:H43 serotype Decreases
0 1 Escherichia coli O157:H7 serotype Decreases
0 1 Escherichia coli O157:NM serotype Decreases
0 1 Escherichia coli O16:H6 serotype Decreases
0 1 Escherichia coli O165:H25 serotype Decreases
0 1 Escherichia coli O167:H26 serotype Decreases
0 1 Escherichia coli O174:H2 serotype Decreases
0 1 Escherichia coli O174:H21 serotype Decreases
0 1 Escherichia coli O174:H8 serotype Decreases
0 1 Escherichia coli O176:H45 serotype Decreases
0 1 Escherichia coli O177:NM serotype Decreases
0 1 Escherichia coli O2:H6 serotype Decreases
0 1 Escherichia coli O2:K2:H1 serotype Decreases
0 1 Escherichia coli O25:H1 serotype Decreases
0 1 Escherichia coli O25:NM serotype Decreases
0 1 Escherichia coli O26:H1 serotype Decreases
0 1 Escherichia coli O26:H11 serotype Decreases
0 1 Escherichia coli O28ac:NM serotype Decreases
0 1 Escherichia coli O29:H4 serotype Decreases
0 1 Escherichia coli O32:H37 serotype Decreases
0 1 Escherichia coli O39:NM serotype Decreases
0 1 Escherichia coli O44:H18 serotype Decreases
0 1 Escherichia coli O45:H2 serotype Decreases
0 1 Escherichia coli O6:H16 serotype Decreases
0 1 Escherichia coli O6:H16:CFA/II serotype Decreases
0 1 Escherichia coli O6:K2:H1 serotype Decreases
0 1 Escherichia coli O69:H11 serotype Decreases
0 1 Escherichia coli O7:H4 serotype Decreases
0 1 Escherichia coli O7:K1 serotype Decreases
0 1 Escherichia coli O78:H12 serotype Decreases
0 1 Escherichia coli O78:H4 serotype Decreases
0 1 Escherichia coli O79:H7 serotype Decreases
0 1 Escherichia coli O8:H8 serotype Decreases
0 1 Escherichia coli O81:NM serotype Decreases
0 1 Escherichia coli O83:H1 serotype Decreases
0 1 Escherichia coli O86:H34 serotype Decreases
0 1 Escherichia coli O89m:H10 serotype Decreases
0 1 Escherichia coli O89m:H9 serotype Decreases
0 1 Escherichia coli O9:H10 serotype Decreases
0 1 Escherichia coli O91:H14 serotype Decreases
0 1 Escherichia coli O91:NM serotype Decreases
0 1 Escherichia coli O99:H6 serotype Decreases
0 1 Escherichia coli ONT:H33 serotype Decreases
1 0 Lacrimispora saccharolytica species Decreases
1 0 Bilophila wadsworthia species Decreases
1 0 Segatella copri species Decreases
1 0 Clostridioides difficile species Decreases
1 0 Escherichia coli species Decreases
1 0 Collinsella aerofaciens species Decreases
1 0 Bacteroides xylanisolvens species Decreases
1 0 Bifidobacterium adolescentis species Decreases
1 0 Ruminococcus bromii species Decreases
1 0 Parabacteroides merdae species Decreases
0 1 Shigella dysenteriae species Decreases
1 0 Bifidobacterium longum species Decreases
0 1 Shigella flexneri species Decreases
0 1 Escherichia albertii species Decreases
1 0 Bacteroides fragilis species Decreases
1 0 Bacteroides ovatus species Decreases
1 0 Roseburia hominis species Decreases
0 1 Escherichia fergusonii species Decreases
1 0 Blautia obeum species Decreases
0 1 Segatella bryantii species Decreases
0 1 Shigella boydii species Decreases
0 1 Leyella stercorea species Decreases
1 0 Veillonella parvula species Decreases
1 0 Bacteroides caccae species Decreases
0 1 Shigella sonnei species Decreases
0 1 Parolsenella catena species Decreases
0 1 Escherichia marmotae species Decreases
0 1 Parolsenella massiliensis species Decreases
0 1 Prevotella intermedia species Decreases
0 1 Escherichia sp. E4742 species Decreases
0 1 Bacteroides sp. DH3716P species Decreases
0 1 Bifidobacterium angulatum species Decreases
0 1 Collinsella stercoris species Decreases
0 1 Leyella lascolaii species Decreases
0 1 Bacteroides luhongzhouii species Decreases
0 1 Paraprevotella clara species Decreases
0 1 Prevotella bivia species Decreases
1 0 Mediterraneibacter gnavus species Decreases
1 0 Coprococcus comes species Decreases
0 1 Coprococcus catus species Decreases
0 1 Bifidobacterium breve species Decreases
0 1 Subdoligranulum variabile species Decreases
0 1 Wansuia hejianensis species Decreases
0 1 Prevotella dentalis species Decreases
0 1 Clostridium sp. M62/1 species Decreases
1 0 Streptococcus salivarius species Decreases
1 0 Bacteroides uniformis species Decreases
1 0 Roseburia intestinalis species Decreases
1 0 Lacticaseibacillus paracasei species Decreases
1 0 Enterocloster bolteae species Decreases
1 0 Clostridium perfringens species Decreases
0 1 Bifidobacterium longum subsp. infantis subspecies Decreases
0 1 Bifidobacterium longum subsp. longum subspecies Decreases
0 1 Bifidobacterium longum subsp. suillum subspecies Decreases
0 1 Bifidobacterium longum subsp. suis subspecies Decreases
0 1 Lacticaseibacillus paracasei subsp. paracasei subspecies Decreases
0 1 Lacticaseibacillus paracasei subsp. tolerans subspecies Decreases

Impact of beta-escin non-drug on Conditions from US National Library of Medicine

A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.

We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive   X|increases + Y|decrease = Negative.

Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.

Condition Positive Impact Negative Impact Benefit Ratio Impact
Abdominal Aortic Aneurysm 0.3 0.3
Acne 0.2 -0.2
ADHD 1.7 0.1 16
Age-Related Macular Degeneration and Glaucoma 0.1 0.2 -1
Allergic Rhinitis (Hay Fever) 1.1 1.6 -0.45
Allergies 4 2 1
Allergy to milk products 1.3 0.9 0.44
Alopecia (Hair Loss) 0.4 0.4
Alzheimer's disease 2.7 2.9 -0.07
Amyotrophic lateral sclerosis (ALS) Motor Neuron 1 0.8 0.25
Ankylosing spondylitis 2.6 0.4 5.5
Anorexia Nervosa 0.7 0.9 -0.29
Antiphospholipid syndrome (APS) 0.7 0.3 1.33
Asthma 2.1 1 1.1
Atherosclerosis 1.8 0.2 8
Atrial fibrillation 1.3 1.9 -0.46
Autism 3.5 4.2 -0.2
Autoimmune Disease 0.7 0.3 1.33
Barrett esophagus cancer 0.1 0 0
benign prostatic hyperplasia 0.5 0.1 4
Biofilm 0.9 0.9
Bipolar Disorder 1.3 0.4 2.25
Brain Trauma 0.5 0.6 -0.2
Breast Cancer 0.6 0.6
Cancer (General) 0.1 1.1 -10
Carcinoma 1.7 1 0.7
Celiac Disease 1.5 1.5 0
Cerebral Palsy 0.5 0.5 0
Chronic Fatigue Syndrome 2.3 2.1 0.1
Chronic Kidney Disease 2.1 0.7 2
Chronic Lyme 0.6 0.2 2
Chronic Obstructive Pulmonary Disease (COPD) 0.9 0.3 2
Chronic Urticaria (Hives) 1.1 0.9 0.22
Coagulation / Micro clot triggering bacteria 1.3 0.5 1.6
Cognitive Function 1 0.3 2.33
Colorectal Cancer 2.9 1.3 1.23
Constipation 0.8 0.2 3
Coronary artery disease 1.7 0.8 1.13
COVID-19 4.3 3.7 0.16
Crohn's Disease 3.7 1.5 1.47
Cushing's Syndrome (hypercortisolism) 0.1 -0.1
cystic fibrosis 0.9 0.9 0
d-lactic acidosis (one form of brain fog) 0.6 0.6
deep vein thrombosis 1.5 0.5 2
Denture Wearers Oral Shifts 0.3 0.3
Depression 4 3.7 0.08
Dermatomyositis 0 0.2 0
Eczema 0.8 1 -0.25
Endometriosis 1.9 1.1 0.73
Eosinophilic Esophagitis 0.1 -0.1
Epilepsy 2.2 0.9 1.44
erectile dysfunction 0.6 0.2 2
Fibromyalgia 0.9 1.2 -0.33
Functional constipation / chronic idiopathic constipation 2.8 2.2 0.27
gallstone disease (gsd) 1.9 0.3 5.33
Gastroesophageal reflux disease (Gerd) including Barrett's esophagus 0.4 0.3 0.33
Generalized anxiety disorder 1.6 0.7 1.29
giant cell arteritis 0 0
Glioblastoma 0 0
Gout 1 0.3 2.33
Graves' disease 1 1.1 -0.1
Gulf War Syndrome 0.2 0.5 -1.5
Halitosis 0.3 0 0
Hashimoto's thyroiditis 1.1 0.6 0.83
Heart Failure 2.4 0.6 3
hemorrhagic stroke 0.2 0.2
Hidradenitis Suppurativa 0.5 0.1 4
High Histamine/low DAO 0.7 0.4 0.75
hypercholesterolemia (High Cholesterol) 0.6 0.6
hyperglycemia 1.4 0.6 1.33
Hyperlipidemia (High Blood Fats) 0.8 0.3 1.67
hypersomnia 0.7 -0.7
hypertension (High Blood Pressure 1.9 2.4 -0.26
Hypothyroidism 0.1 0.4 -3
Hypoxia 0.5 0.5
IgA nephropathy (IgAN) 0.5 1.8 -2.6
Inflammatory Bowel Disease 4.1 5.1 -0.24
Insomnia 0.5 0.7 -0.4
Intelligence 0.9 0.6 0.5
Intracranial aneurysms 0.7 0.3 1.33
Irritable Bowel Syndrome 3.1 1.7 0.82
ischemic stroke 1.8 0.7 1.57
Liver Cirrhosis 3.2 1.7 0.88
Long COVID 1.7 3.4 -1
Low bone mineral density 0.1 -0.1
Lung Cancer 1 0.3 2.33
Lymphoma 0.5 0.5
Mast Cell Issues / mastitis 0.6 0.4 0.5
ME/CFS with IBS 0.1 0.8 -7
ME/CFS without IBS 0.2 0.4 -1
membranous nephropathy 0 0
Menopause 1 0.1 9
Metabolic Syndrome 4.4 2.9 0.52
Mood Disorders 3.6 3.2 0.13
multiple chemical sensitivity [MCS] 0.2 0.1 1
Multiple Sclerosis 2.5 1.9 0.32
Multiple system atrophy (MSA) 0.3 0.5 -0.67
myasthenia gravis 0.6 0.1 5
neuropathic pain 0.7 -0.7
Neuropathy (all types) 0.2 0.5 -1.5
neuropsychiatric disorders (PANDAS, PANS) 0.7 0.7
Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic 2.9 1.7 0.71
NonCeliac Gluten Sensitivity 0.7 0.3 1.33
Obesity 4.6 2.4 0.92
obsessive-compulsive disorder 3.4 1.3 1.62
Osteoarthritis 0.8 0.5 0.6
Osteoporosis 1 0.4 1.5
pancreatic cancer 0 0 0
Parkinson's Disease 4.6 2.9 0.59
Polycystic ovary syndrome 2.8 1.5 0.87
Postural orthostatic tachycardia syndrome 0 0.2 0
Premenstrual dysphoric disorder 0.6 0.2 2
primary biliary cholangitis 0.1 0.4 -3
Primary sclerosing cholangitis 0.6 1 -0.67
Psoriasis 2.1 1.1 0.91
rheumatoid arthritis (RA),Spondyloarthritis (SpA) 4 1.2 2.33
Rosacea 0.4 0.1 3
Schizophrenia 2.6 1 1.6
scoliosis 0.7 0.5 0.4
Sjögren syndrome 1.8 1.1 0.64
Sleep Apnea 0.8 0.4 1
Slow gastric motility / Gastroparesis 1 0.2 4
Small Intestinal Bacterial Overgrowth (SIBO) 0.9 0.3 2
Stress / posttraumatic stress disorder 1.4 0.9 0.56
Systemic Lupus Erythematosus 1.9 1.2 0.58
Tic Disorder 0.2 1.4 -6
Tourette syndrome 0 0.1 0
Type 1 Diabetes 2.1 1.5 0.4
Type 2 Diabetes 3.8 2.6 0.46
Ulcerative colitis 2.2 3.3 -0.5
Unhealthy Ageing 1.7 0.5 2.4
Vitiligo 1 0.5 1

Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.

Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served.   Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 Β§β€―1030, CETS No.185, CFAA   Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license.   Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models.   Inventions /Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]